Your browser doesn't support javascript.
loading
Application of Physiologically Based Pharmacokinetic Modeling to Predict Drug Exposure and Support Dosing Recommendations for Potential Drug-Drug Interactions or in Special Populations: An Example Using Tofacitinib.
Tse, Susanna; Dowty, Martin E; Menon, Sujatha; Gupta, Pankaj; Krishnaswami, Sriram.
Affiliation
  • Tse S; Department of Pharmacokinetics, Dynamics, and Metabolism, Pfizer Inc., Groton, Connecticut, USA.
  • Dowty ME; Department of Pharmacokinetics, Dynamics, and Metabolism, Pfizer Inc., Cambridge, Massachusetts, USA.
  • Menon S; Department of Clinical Pharmacology, Pfizer Inc., Groton, Connecticut, USA.
  • Gupta P; Worldwide Business Development, Pfizer Inc., New York, New York, USA.
  • Krishnaswami S; Global Product Development, Pfizer Inc., Groton, Connecticut, USA.
J Clin Pharmacol ; 60(12): 1617-1628, 2020 12.
Article in En | MEDLINE | ID: mdl-32592424

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperidines / Pyrimidines / Protein Kinase Inhibitors / Renal Insufficiency / Liver Diseases Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Clin Pharmacol Year: 2020 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperidines / Pyrimidines / Protein Kinase Inhibitors / Renal Insufficiency / Liver Diseases Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Clin Pharmacol Year: 2020 Document type: Article